AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 292: H399-H407, 2007. First published July 28, 2006; doi:10.1152/ajpheart.01025.2005 Free Article
0363-6135/07 $8.00
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
292/1/H399    most recent
01025.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Z.-S.
Right arrow Articles by Grant, A. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Z.-S.
Right arrow Articles by Grant, A. O.

Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease

Zhu-Shan Zhang,1 Joseph Tranquillo,3 Valentina Neplioueva,1 Nenad Bursac,2 and Augustus O. Grant1

Departments of 1Medicine and 2Biomedical Engineering, Duke University, Durham, North Carolina; and 3Department of Biomedical and Electrical Engineering, Bucknell University, Lewisburg, Pennsylvania

Submitted 27 September 2005 ; accepted in final form 23 June 2006

Some mutations of the sodium channel gene NaV1.5 are multifunctional, causing combinations of LQTS, Brugada syndrome and progressive cardiac conduction system disease (PCCD). The combination of Brugada syndrome and PCCD is uncommon, although they both result from a reduction in the sodium current. We hypothesize that slow conduction is sufficient to cause S-T segment elevation and undertook a combined experimental and theoretical study to determine whether conduction slowing alone can produce the Brugada phenotype. Deletion of lysine 1479 in one of two positively charged clusters in the III/IV inter-domain linker causes both syndromes. We have examined the functional effects of this mutation using heterologous expression of the wild-type and mutant sodium channel in HEK-293-EBNA cells. We show that {Delta}K1479 shifts the potential of half-activation, V1/2m, to more positive potentials (V1/2m = –36.8 ± 0.8 and –24.5 ± 1.3 mV for the wild-type and {Delta}K1479 mutant respectively, n = 11, 10). The depolarizing shift increases the extent of depolarization required for activation. The potential of half-inactivation, V1/2h, is also shifted to more positive potentials (V1/2h = –85 ± 1.1 and –79.4 ± 1.2 mV for wild-type and {Delta}K1479 mutant respectively), increasing the fraction of channels available for activation. These shifts are quantitatively the same as a mutation that produces PCCD only, G514C. We incorporated experimentally derived parameters into a model of the cardiac action potential and its propagation in a one dimensional cable (simulating endo-, mid-myocardial and epicardial regions). The simulations show that action potential and ECG changes consistent with Brugada syndrome may result from conduction slowing alone; marked repolarization heterogeneity is not required. The findings also suggest how Brugada syndrome and PCCD which both result from loss of sodium channel function are sometimes present alone and at other times in combination.

sodium channel; Brugada syndrome; conduction system disease



Address for reprint requests and other correspondence: A. O. Grant, Duke Univ. Medical Center, Box 3504, Durham, NC 27710 (e-mail: grant007{at}mc.duke.edu)




This article has been cited by other articles:


Home page
Circ Arrhythmia ElectrophysiolHome page
A. O. Grant
Cardiac Ion Channels
Circ Arrhythmia Electrophysiol, April 1, 2009; 2(2): 185 - 194.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Casini, H. L. Tan, Z. A. Bhuiyan, C. R. Bezzina, P. Barnett, E. Cerbai, A. Mugelli, A. A.M. Wilde, and M. W. Veldkamp
Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation
Cardiovasc Res, December 1, 2007; 76(3): 418 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. S. Stokoe, R. Balasubramaniam, C. A. Goddard, W. H. Colledge, A. A. Grace, and C. L.-H. Huang
Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/ murine hearts modelling the Brugada syndrome
J. Physiol., May 15, 2007; 581(1): 255 - 275.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.